No significant difference was found between other treatments .
Conclusion Compared with antimuscarinic drugs , PTENS was associated with significant better efficacy considering MVV , but more constipation events in de novo OAB children .
Antimuscarinic drugs showed remarkably better efficacy considering MVV and comparable safety profile compared with urotherapy .
Objective To compare these managements focusing on the efficacy and safety to treat overactive bladder ( OAB ) in children through network meta- analysis ( NMA ) .
The natural history of urinary symptoms during adolescence.
OBJECTIVE To determine the prevalence and natural history of urinary symptoms and incontinence among healthy adolescent schoolchildren . SUBJECTS AND METHODS A prospect i ve longitudinal study using a confidential question naire administered to an original cohort of 1176 local schoolchildren at 11 - 12 years and again at 15 - 16 years old . RESULTS There was a decrease in the prevalence of urinary symptoms with age . Daywetting was reported by 12.5 % of children aged 11 - 12 years and 3.0 % of children aged 15 - 16 years . Nocturnal enuresis was reported by 4.7 % of children at 11 - 12 years and 1.1 % at 15 - 16 years . Some of the children reporting daywetting and nocturnal enuresis at 15 - 16 years old had not reported these symptoms at 11 - 12 years old . CONCLUSION Urinary symptoms become less prevalent with age , but are reported by a significant number of healthy schoolchildren
No significant difference was found between other treatments .
Conclusion Compared with antimuscarinic drugs , PTENS was associated with significant better efficacy considering MVV , but more constipation events in de novo OAB children .
Antimuscarinic drugs showed remarkably better efficacy considering MVV and comparable safety profile compared with urotherapy .
Objective To compare these managements focusing on the efficacy and safety to treat overactive bladder ( OAB ) in children through network meta- analysis ( NMA ) .